In CRISPR and other gene-editing technologies, the scientific community has handed the world an incredible tool: The ability to make precise edits to the DNA in living cells. These technologies could allow us to transform our food, health, and ecological systems. They also raise important questions about risks, benefits, ethics, equity, and more.

Together with key partners in the scientific community, Keystone has brought together leading voices from diverse sectors to discuss the future of gene editing technologies across a variety of applications. CRISPRcon, which launched in 2017 in Berkeley, California, returned June 4-5, 2018 in Boston. CRISPRcon 2018 featured a dynamic, diverse, and provocative lineup of panels, keynotes, interactive discussions and networking opportunities that consider gene editing across a variety of applications, disciplines, geographies, communities, and cultures. Session themes included historical and social contexts for technological innovation, community engagement, technology democratization, and international dynamics.

Learn more at